| Product NDC: | 0574-2020 | 
| Proprietary Name: | Colocort | 
| Non Proprietary Name: | Hydrocortisone | 
| Active Ingredient(s): | 100 mg/60mL & nbsp; Hydrocortisone | 
| Administration Route(s): | RECTAL | 
| Dosage Form(s): | SUSPENSION | 
| Coding System: | National Drug Codes(NDC) | 
| Product NDC: | 0574-2020 | 
| Labeler Name: | Paddock Laboratories, Inc. | 
| Product Type: | HUMAN PRESCRIPTION DRUG | 
| FDA Application Number: | ANDA075172 | 
| Marketing Category: | ANDA | 
| Start Marketing Date: | 19991231 | 
| Package NDC: | 0574-2020-01 | 
| Package Description: | 1 BOTTLE, DISPENSING in 1 BOX (0574-2020-01) > 60 mL in 1 BOTTLE, DISPENSING | 
| NDC Code | 0574-2020-01 | 
| Proprietary Name | Colocort | 
| Package Description | 1 BOTTLE, DISPENSING in 1 BOX (0574-2020-01) > 60 mL in 1 BOTTLE, DISPENSING | 
| Product NDC | 0574-2020 | 
| Product Type Name | HUMAN PRESCRIPTION DRUG | 
| Non Proprietary Name | Hydrocortisone | 
| Dosage Form Name | SUSPENSION | 
| Route Name | RECTAL | 
| Start Marketing Date | 19991231 | 
| Marketing Category Name | ANDA | 
| Labeler Name | Paddock Laboratories, Inc. | 
| Substance Name | HYDROCORTISONE | 
| Strength Number | 100 | 
| Strength Unit | mg/60mL | 
| Pharmaceutical Classes | Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA] |